Javier Martín Broto
Javier Martín Broto
Sarcoma Medical Oncology Consultant, University Hospital Fundacion Jimenez Diaz
Email verificata su
Citata da
Citata da
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv51-iv67, 2018
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a …
JS Gold, M Gönen, A Gutiérrez, JM Broto, X García-del-Muro, TC Smyrk, ...
The lancet oncology 10 (11), 1045-1052, 2009
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv68-iv78, 2018
Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish …
J Martín, A Poveda, A Llombart-Bosch, R Ramos, JA López-Guerrero, ...
J Clin Oncol 23 (25), 6190-6198, 2005
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ...
Annals of Oncology 29, iv79-iv95, 2018
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label …
A Gronchi, S Ferrari, V Quagliuolo, JM Broto, AL Pousa, G Grignani, ...
The Lancet Oncology 18 (6), 812-822, 2017
An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between Sarcoma Patients EuroNet (SPAEN) and European Organization for …
B Kasper, C Baumgarten, J Garcia, S Bonvalot, R Haas, F Haller, ...
Annals of Oncology 28 (10), 2399-2408, 2017
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research …
X García-del-Muro, A López-Pousa, J Maurel, J Martín, J Martínez-Trufero, ...
Journal of Clinical Oncology 29 (18), 2528-2533, 2011
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases
J Lasota, CL Corless, MC Heinrich, M Debiec-Rychter, R Sciot, ...
Modern pathology 21 (4), 476-484, 2008
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
WD Tap, H Gelderblom, E Palmerini, J Desai, S Bauer, JY Blay, T Alcindor, ...
The Lancet 394 (10197), 478-487, 2019
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
A Gronchi, S Frustaci, M Mercuri, J Martin, A Lopez-Pousa, P Verderio, ...
J Clin Oncol 30 (8), 850-856, 2012
Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor EraAdvanced PDGFRA-Mutant GIST
PA Cassier, E Fumagalli, P Rutkowski, P Schöffski, M Van Glabbeke, ...
Clinical Cancer Research 18 (16), 4458-4464, 2012
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
S Stacchiotti, A Gronchi, P Fossati, T Akiyama, C Alapetite, M Baumann, ...
Annals of Oncology 28 (6), 1230-1242, 2017
Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial
WD Tap, AJ Wagner, P Schöffski, J Martin-Broto, A Krarup-Hansen, ...
Jama 323 (13), 1266-1276, 2020
Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: a European Organisation for Research and …
P Casali, A Le Cesne, AP Velasco, D Kotasak, P Rutkowski, ...
American Society of Clinical Oncology, 2015
GEIS guidelines for gastrointestinal sarcomas (GIST)
A Poveda, XG Del Muro, JA López-Guerrero, R Cubedo, V Martínez, ...
Cancer treatment reviews 55, 107-119, 2017
Giant cell tumour of bone: new treatments in development
A López-Pousa, JM Broto, T Garrido, J Vázquez
Clinical and Translational Oncology 17 (6), 419-430, 2015
A phase II trial of temozolomide as a 6‐week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas
X Garcia del Muro, A Lopez‐Pousa, J Martin, JM Buesa, ...
Cancer 104 (8), 1706-1712, 2005
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ...
Annals of Oncology 32 (11), 1348-1365, 2021
Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy
S Stacchiotti, P Verderio, A Messina, C Morosi, P Collini, ...
Cancer 118 (23), 5857-5866, 2012
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20